ASH 2020: Dr. Adrian Wiestner on early detection of BTK mutations preceding ibrutinib relapse in chronic lymphocytic leukemia (CLL) ASH 2020: Dr. Adrian Wiestner on early detection of BTK mutations preceding ibrutinib relapse in chronic lymphocytic leukemia (CLL)... May 6, 20212020 ConferencesBy Brad Hedrick
iwCLL 2019: Dr. Danilov Discusses the Role of B-cells and T-cells in CLL (Chronic Lymphocytic Leukemia) iwCLL 2019: Dr. Danilov Discusses the Role of B-cells and T-cells in CLL (Chronic Lymphocytic Leukemia)... May 6, 20212019 ConferencesBy Brad Hedrick
ASH 2020: Dr. Paul Barr on Combining Rituximab with BTK Inhibitors for Treatment of Chronic Lymphocytic Leukemia (CLL) Dr. Paul Barr discusses which BTK inhibitor works best in combination with rituximab. At the annual meeting of the American... April 30, 20212020 ConferencesBy Brad Hedrick
ASH 2020: Dr. Paul Barr’s Update on the Combination of Umbralisib, Ublituximab, and Venetoclax for Treatment of Chronic Lymphocytic Leukemia (CLL) ASH 2020: Dr. Paul Barr’s Update on the Combination of Umbralisib, Ublituximab, and Venetoclax for Treatment of Chronic Lymphocytic Leukemia... April 23, 20212020 ConferencesBy Brad Hedrick
ASH 2020: Dr. Ian Flinn on Combination Zanubrutinib and Venetoclax for Treating Chronic Lymphocytic Leukemia (CLL) ASH 2020: Dr. Ian Flinn on Combination Zanubrutinib and Venetoclax for Treating Chronic Lymphocytic Leukemia (CLL)... April 22, 20212020 ConferencesBy Brad Hedrick
ASH 2020: Dr. Arnon Nagler on Safety and Efficacy of CD19-CAR T Cells in Richter’s Transformation After Targeted Therapy for Chronic Lymphocytic Leukemia (CLL) ASH 2020: Dr. Arnon Nagler on Safety and Efficacy of CD19-CAR T Cells in Richter’s Transformation After Targeted Therapy for... April 15, 20212020 ConferencesBy Brad Hedrick
ASH 2020: Dr. Tanya Siddiqi Provides an Update on the TRANSCEND CLL 004 Trial: Lisocabtagene Maraleucel (liso-cel) in Combination with Ibrutinib for Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) ASH 2020: Dr. Tanya Siddiqi provides an Update on the TRANSCEND CLL 004 Trial: Lisocabtagene Maraleucel (liso-cel) in Combination with... April 7, 20212020 ConferencesBy Brad Hedrick
ASH 2020: Dr. Ian Flinn on Outpatient Debulking Prior to Venetoclax Treatment for Chronic Lymphocytic Leukemia (CLL) ASH 2020: Dr. Richard Furman on selecting chronic lymphocytic leukemia (CLL) therapies during the COVID-19 pandemic ... March 26, 20212020 ConferencesBy Brad Hedrick
ASH 2020: Dr. Richard Furman on Selecting Chronic Lymphocytic Leukemia (CLL) Therapies During the COVID-19 Pandemic ASH 2020: Dr. Richard Furman on selecting chronic lymphocytic leukemia (CLL) therapies during the COVID-19 pandemic ... March 21, 20212020 ConferencesBy Brad Hedrick
ASH 2020: Dr. Anthony Mato Discusses the Impact of del(17p) on Survival of Patients with Chronic Lymphocytic Leukemia (CLL) Treated with First-Line Ibrutinib ASH 2019: Dr. David Maloney on CAR-T therapy in CLL (chronic lymphocytic leukemia)... March 17, 20212020 Conferences, Conference CoverageBy Brad Hedrick
